Stay updated on Apremilast-Dupilumab Combo in Eczema Clinical Trial

Sign up to get notified when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apremilast-Dupilumab Combo in Eczema Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a funding-status notice at the top of the page about potential data currency issues and a Revision banner showing v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:17:59.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a glossary display option and updated labeling for QC-related items (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with a revision notice (Revision: v3.4.0), replacing the previous variants (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:51:37.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.3.3 to v3.3.4 in the page footer. No changes to the study content are apparent.
    Difference
    0.1%
    Check dated 2026-01-14T01:32:45.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a dedicated Locations section featuring Massachusetts (Boston, MA) as a study location and removed the prior Massachusetts Locations entry; the page revision was updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link in the footer was removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:13:44.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.2.0 on the page. It is a minor site update and does not modify study details or user actions.
    Difference
    0.1%
    Check dated 2025-11-24T18:20:14.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Removed the banner noting a lapse in government funding and related operating status; the page no longer displays that notice.
    Difference
    0.4%
    Check dated 2025-11-17T17:57:47.000Z thumbnail image

Stay in the know with updates to Apremilast-Dupilumab Combo in Eczema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.